The Senate passed a bill on Wednesday by a vote of 93 to 1that would give the FDA more power to police pharmaceutical manufacturers. The bill allows the FDA to police drug safety, order changes in drug labels, regulate advertising and restrict the use and distribution of medicines found to pose serious risks to consumers. The bill aimed to fundamentally change the philosophy and operations of the FDA as an agency, requiring it to focus on the entire life cycle of a drug, not just the years before its approval. If passed, the bill requires the government to establish a surveillance system to track the adverse effects of prescription drugs.
For the full article.